Dose-Dense Chemotherapy Improves Outcomes in Breast Cancer

Dose intensification of breast cancer chemotherapy significantly reduces the risk for recurrence and mortality from breast cancer at 10 years compared to standard chemotherapy given every 3 weeks.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply